Increased circulatory IL-6 has been long established as a negative prognostic indicator in human lymphoma patients and simultaneous elevations of IL-6 and VEGFA are independent predictors of survival in aggressive NHL50,51. This evidence concerns the gene VEGFA and lymphoma.